ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 165 filers reported holding ANIKA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $491,000 | -11.1% | 22,000 | 0.0% | 0.10% | +9.5% |
| Q1 2022 | $552,000 | -29.9% | 22,000 | 0.0% | 0.10% | -15.9% |
| Q4 2021 | $788,000 | -15.8% | 22,000 | 0.0% | 0.11% | -16.9% |
| Q3 2021 | $936,000 | -1.7% | 22,000 | 0.0% | 0.14% | +7.1% |
| Q2 2021 | $952,000 | +6.1% | 22,000 | 0.0% | 0.13% | 0.0% |
| Q1 2021 | $897,000 | -9.9% | 22,000 | 0.0% | 0.13% | -9.3% |
| Q4 2020 | $996,000 | +27.9% | 22,000 | 0.0% | 0.14% | +4.5% |
| Q3 2020 | $779,000 | -6.1% | 22,000 | 0.0% | 0.13% | +0.8% |
| Q2 2020 | $830,000 | +79.3% | 22,000 | +37.5% | 0.13% | +77.3% |
| Q1 2020 | $463,000 | +78.8% | 16,000 | +220.0% | 0.08% | +188.5% |
| Q4 2019 | $259,000 | -52.8% | 5,000 | -50.0% | 0.03% | -53.6% |
| Q3 2019 | $549,000 | -66.2% | 10,000 | -75.0% | 0.06% | -64.6% |
| Q2 2019 | $1,625,000 | +34.3% | 40,000 | 0.0% | 0.16% | +31.7% |
| Q1 2019 | $1,210,000 | -10.0% | 40,000 | 0.0% | 0.12% | -18.4% |
| Q4 2018 | $1,344,000 | -3.4% | 40,000 | +21.2% | 0.15% | +20.5% |
| Q3 2018 | $1,392,000 | +155.9% | 33,000 | +94.1% | 0.12% | +154.2% |
| Q2 2018 | $544,000 | – | 17,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |